Sign in or register to see full information and data.

Studies / CAVD 503


Study information

Grant Affiliation:Haynes: Isolation of 10E8-like bNAbs from CHAVI 001
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Production
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2015-08-28
Study Made Public:2016-12-30


Epitope Mapping and Development of Neutralization Breadth in a gp41 Distal MPER Broadly Neutralizing Antibody (bnAb) Clonal Lineage


CAVD 503 is an immunogenicity study of monoclonal antibodies using MPER peptide fluorophore-labeled hooks to isolate MPER-reactive memory B cells from two CHAVI001 chronically HIV-infected individuals from Africa.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.